Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Turoctocog alfa for treatment of bleeding in severe hemophilia A in China
CTR20160811Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of turoctocog alfa in hemophilia A, sponsored by Novo Nordisk. Started Dec 2016; status: completed.
02
Drugs
turoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20160811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160811.